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Fusion of the HIV envelope with the target cell membrane is a critical step of HIV 
entry into the target cell. Several peptides based on the C-region of HIV gp41 have 
been used in clinical trials as possible HIV fusion inhibitors. Among these are T-1249 
and  T-20 (also  known as  enfurvitide;  see fig.  1).  Despite  recent  works,  a  detailed 
molecular  picture  of  the  inhibitory  mechanism  of  these  molecules  is  still  lacking. 
These peptides are usually depicted as α-helices by analogy with the structure of the 
sequence of the gp41 protein with which they are homologous. However,  structures 
like these would not explain the ability  that  the two fusion inhibitors  have to  both 
become solvated by water and interact effectively with cell membranes.
This  led  us  to  study  the  structure  and  conformational  behavior  of  all  these 
peptides. To this effect, extensive molecular dynamics simulations (total time 400 ns) 
with  explicit  solvent  (SPC water)  were carried  out  to  investigate  the structure and 
conformational behavior of T-1249 and T-20, as well as shorter homologous peptides 
CTP and 3f5 (see fig. 1), which show no inhibitory action. The monitored parameters 
include  mean  square  displacement  relative  to  the  initial  conformation  (α-helix 
structures in all cases), secondary structure, solvent accessible surface and radius of 
gyration. We found that the studied peptides have no stable structure in solution in the 
time scale studied. Additionally, the solvent accessible area varies significantly during 
the simulation. Our findings suggest that these peptides may assume not only one but 
several possible sets of structures in solution, some of which more adequate to interact 
with  the  solvent,  whereas  others  might  be  better  suited  to  interact  with  cell 
membranes.
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